PFM Health Sciences’s Kodiak Sciences KOD Stock Holding History

PFM Health Sciences’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.53M	Buy	193,315 +78,596	+69%	+$3.06M	0.65%	53
2026 Q1	$4.37M	Buy	+114,719	New	+$2.96M	0.4%	64

Other funds holding KOD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

PFM Health Sciences's KOD Position: Q2 2026 in Review

PFM Health Sciences increased its Kodiak Sciences (KOD) stake by 69% in Q2 2026, buying an estimated $3.06M and bringing the position to 193,315 shares worth $7.53M. The position accounts for 0.65% of the portfolio, ranked #53.

PFM Health Sciences first reported a position in KOD in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

PFM Health Sciences held 193,315 shares of Kodiak Sciences worth $7.53M as of Q2 2026.
PFM Health Sciences bought 78,596 Kodiak Sciences shares in Q2 2026, an estimated $3.06M.
Kodiak Sciences made up 0.65% of PFM Health Sciences's portfolio in Q2 2026, its #53 holding.
PFM Health Sciences first reported a position in Kodiak Sciences in Q1 2026 and has held it in 2 quarters since.
201 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.